The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
AbCellera Biologics Inc(NASDAQ:ABCL) 
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, AI-powered drug discovery platform searches and analyzes the database of natural immune systems to find antibodies that can be developed as drugs. As of December 31, 2020, the company had 103 discovery programs that are e...
Website: https://www.abcellera.com/
Founded: 2012
Full Time Employees: 174
CEO: Carl Hansen
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
AbCellera Biologics Days Payable Outstanding ttm (DPO)
AbCellera Biologics Days Receivable Outstanding ttm (DSO)
AbCellera Biologics Days Inventory Outstanding ttm (DIO)
AbCellera Biologics Op Cashflow Per Share ttm
AbCellera Biologics Free Cashflow Per Share ttm
AbCellera Biologics Cash Per Share ttm
AbCellera Biologics P/S ratio ttm
AbCellera Biologics (GAAP) P/E ratio ttm
AbCellera Biologics P/B ratio ttm
No extra charts and metrics for this ticker.